Even though the authors did not further investigate the molecular pathway underlying the inhibition of migration, previous studies in the literature provide a possible explanation: paclitaxel promoted the activation of NF-κB in breast cancer cells while curcumin inhibited its expression by inhibiting IκBα kinase activation. Here, NFKB1 is linked to breast cancer.